View in EDS HTML Full Text PDF Full Text

Impact of hepatitis C treatment status on risk of Parkinson's disease and secondary parkinsonism in the era of direct‐acting antivirals.

Saved in:
Bibliographic Details
Title: Impact of hepatitis C treatment status on risk of Parkinson's disease and secondary parkinsonism in the era of direct‐acting antivirals.
Authors: Selim, Ranya1 (AUTHOR), Gordon, Stuart C.1,2 (AUTHOR), Zhou, Yueren3 (AUTHOR), Zhang, Talan4 (AUTHOR), Lu, Mei4 (AUTHOR), Daida, Yihe G.5 (AUTHOR), Boscarino, Joseph A.6 (AUTHOR), Schmidt, Mark A.7 (AUTHOR), Trudeau, Sheri4 (AUTHOR), Rupp, Loralee B.8 (AUTHOR), Gonzalez, Humberto C.1,2 (AUTHOR) hgonzal1@hfhs.org
Source: Journal of Viral Hepatitis. Jun2023, Vol. 30 Issue 6, p544-550. 7p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:13520504
DOI:10.1111/jvh.13826